GE HealthCare in talks over possible $1 billion deal for Sofie Biosciences, FT reports

GE HealthCare Technologies is reportedly in talks to acquire radiopharmaceutical developer Sofie Biosciences for about $1 billion, according to the Financial Times. The potential transaction would expand GE HealthCare's exposure to radiopharmaceuticals and molecular imaging, though discussions remain ongoing and no deal has been confirmed.